Boston Scientific Corporation
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Director or officer changeSep 23 →Insiders3 insiders bought $554,012 in 4 open-market buys. 4 insiders sold $24.3M, all 9 sales on a 10b5-1 plan.→HoldersBlackRock 7.4%Vanguard 5.5%State Street 4.0%→Financing →PeersClosest companies: EW, GEHC, MDT→
From the filings
Figures
- Revenue
- $21.00Blast 12 months
- Net income
- $3.67Blast 12 months
- Operating cash flow
- $4.34Blast 12 months
- Cash and equivalents
- $539.0Mat the last balance sheet
- Total debt
- $12.62Bat the last balance sheet
- Shares outstanding
- 1.75B shareson issue